Fairfax Financial Holdings acquires Kennedy-Wilson

Fairfax Financial Holdings Limited has announced the acquisition of Kennedy-Wilson Holdings, Inc. as part of a consortium led by William McMorrow, the latter company's CEO. The deal, valued at $1.65 billion, is structured as an all-cash transaction whereby the consortium, including key senior executives and affiliates, will acquire all outstanding common shares of Kennedy Wilson, excluding those owned by consortium members. The agreement stipulates a purchase price of $10.90 per share, marking a 46% premium over Kennedy Wilson's stock price prior to the acquisition proposal.

Fairfax has committed the full $1.65 billion necessary to finance the purchase price and related costs, ensuring the transaction proceeds without a financing condition. Following the acquisition, operational control will remain with Kennedy Wilson’s existing management, helmed by McMorrow. However, Fairfax is anticipated to hold the majority of the economic interest in Kennedy Wilson. The deal received approval from Kennedy Wilson's board, backed by a special committee of independent directors and their advisors, following the consortium's proposal dated November 4, 2025.

The acquisition aligns with Fairfax’s strategy of enhancing its portfolio within the real estate investment sector and ensures continuity in Kennedy Wilson’s current management structure, potentially leveraging McMorrow’s leadership to drive future growth. This move provides Kennedy Wilson with substantial capital resources and strategic oversight as part of a larger financial group.

In the broader real estate investment landscape, this transaction underscores the increasing consolidation trend as major financial entities, like Fairfax, seek to strengthen their positions by acquiring established players. Competitors might feel pressure to secure similar alliances or pursue mergers to sustain their competitive edge and access capital.

The transaction is slated for completion in the second quarter of 2026, pending customary conditions such as shareholder and regulatory approvals. Kennedy Wilson’s shares will be delisted from the New York Stock Exchange post-transaction. Meanwhile, shareholder votes, excluding consortium-affiliated shareholders, are requisite for proceeding. Until required approvals are secured, Kennedy Wilson’s board may continue distributing ordinary course dividends.